Example: Heart Attack

Latest Trials

NCT03816358

Recruiting

Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

Conditions: Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8, Stage IIB Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma
NCT03789201

Recruiting

Exploring the Relationship Between Brain Asymmetry and Attention

Conditions: Normal Physiology
NCT03628235

Recruiting

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Conditions: Huntington's Disease
NCT03745144

Recruiting

Effects of Cladribine Tablets on the PK of Microgynon®

Conditions: Relapsing Multiple Sclerosis (RMS)
NCT03740529

Recruiting

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Conditions: Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma, Small Lymphocytic Lymphoma
NCT03666533

Recruiting

Transcranial Direct Current Stimulation for Post-stroke Gait Rehab

Conditions: Stroke, Gait Impairment
NCT03663790

Recruiting

Effects of Gait Retraining on Lower Extremity Biomechanics

Conditions: Knee Osteoarthritis
NCT03599622

Recruiting

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Conditions: Granulomatous Colitis, Crohn's Disease, Crohn's Enteritis, Granulomatous Enteritis
NCT03433924

Recruiting

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Conditions: Urinary Bladder Cancer
NCT03427424

Recruiting

Imaging Biomarker for Addiction Treatment Outcome

Conditions: Opioid-Related Disorders, Alcohol-Related Disorders
NCT03425422

Recruiting

ANTHEM-HFrEF Pivotal Study

Conditions: Heart Failure, Heart Failure, Congestive, Heart Failure, Systolic
NCT03368079

Recruiting

Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia

Conditions: Oropharyngeal Dysphagia
NCT03364803

Recruiting

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Conditions: Cushing's Disease, Cushing Syndrome, Cushing Disease
NCT03446417

Recruiting

A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

Conditions: Carcinoma, Non-Small-Cell Lung
NCT03446040

Recruiting

An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread

Conditions: Advanced Cancer
NCT03441958

Recruiting

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Conditions: Multiple Myeloma
NCT03209479

Recruiting

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

Conditions: Multiple Sclerosis
NCT03310190

Recruiting

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

Conditions: Chronic Lymphocytic Leukemia
NCT03250299

Recruiting

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Conditions: Glioblastoma, MGMT-Unmethylated Glioblastoma
NCT03179436

Recruiting

Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

Conditions: Advanced Solid Tumors
NCT03226470

Recruiting

Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

Conditions: Human Papillomavirus-Related Malignant Neoplasm
NCT03473223

Recruiting

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Conditions: Acute Coronary Syndrome
NCT03520790

Recruiting

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT03519178

Recruiting

A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy

Conditions: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
NCT03455504

Recruiting

Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia

Conditions: Acute Myeloid Leukemia